Biochemistry
Cannabinoid Receptor 2 Agonists Show Potential in Treating HIV-Associated Neuroinflammation
Researchers at the University of Pennsylvania have made a groundbreaking discovery in the fight against HIV/AIDS. According to their study, published in the Journal of Neuroimmune Pharmacology, cannabinoid receptor 2 (CB) agonists have shown promise in reducing HIV replication and inflammation in the central nervous system (CNS). The study